Titan Medical (TMDIF) Competitors

Profound Medical (NASDAQ:PROF) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, community ranking, earnings, profitability, dividends, media sentiment and analyst recommendations.

Is PROF or TMDIF more profitable?

Titan Medical has a net margin of 0.00% compared to Profound Medical's net margin of -349.41%. Titan Medical's return on equity of -82.31% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Profound Medical	-349.41%	-85.22%	-64.87%
Titan Medical	N/A	-82.31%	-51.47%

Which has more risk and volatility, PROF or TMDIF?

Profound Medical has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.

Which has better valuation & earnings, PROF or TMDIF?

Titan Medical has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$10.68M	17.41	-$28.57M	-$1.12	-5.53
Titan Medical	$17.63M	2.78	$6.95M	$0.05	8.60

Does the MarketBeat Community favor PROF or TMDIF?

Profound Medical received 40 more outperform votes than Titan Medical when rated by MarketBeat users.

Company	Underperform	Outperform
Profound Medical	Outperform Votes 40 72.73%	Underperform Votes 15 27.27%
Titan Medical	N/A	N/A

Do analysts prefer PROF or TMDIF?

Profound Medical currently has a consensus target price of $14.25, indicating a potential upside of 130.21%. Given Profound Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Profound Medical is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Do insiders and institutionals hold more shares of PROF or TMDIF?

47.9% of Profound Medical shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Does the media favor PROF or TMDIF?

In the previous week, Profound Medical had 7 more articles in the media than Titan Medical. MarketBeat recorded 8 mentions for Profound Medical and 1 mentions for Titan Medical. Titan Medical's average media sentiment score of 0.75 beat Profound Medical's score of 0.50 indicating that Titan Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Profound Medical	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Titan Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Profound Medical and Titan Medical tied by winning 9 of the 18 factors compared between the two stocks.